Engineering the gut microbiota to treat chronic diseases

被引:0
作者
Noura S. Dosoky
Linda S. May-Zhang
Sean S. Davies
机构
[1] Vanderbilt University,Department of Pharmacology and Division of Clinical Pharmacology
来源
Applied Microbiology and Biotechnology | 2020年 / 104卷
关键词
Gut microbiota; Engineered bacteria; Cancer; Diabetes; Inflammatory bowel disease; Atherosclerosis; Obesity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:7657 / 7671
页数:14
相关论文
共 804 条
[41]  
Nicolas P(2018) leads to heterogeneous accumulation within tumors Appl Environ Microbiol 84 e02334-2774
[42]  
Piersma S(2012)Tumour-targeted delivery of TRAIL using J Ind Microbiol Biotechnol 39 383-22622
[43]  
Rügheimer F(2007) enhances breast cancer survival in mice Gastroenterology 133 517-305
[44]  
Becher D(2009)In tumors J Immunol 183 2390-254
[45]  
Bessieres P(2018) migrate away from vasculature toward the transition zone and induce apoptosis Nat Biotechnol 36 857-293
[46]  
Bidnenko E(2014)Intestinal microbiota in human health and disease: the impact of probiotics PLoS One 9 e80050-184
[47]  
Denham EL(2010)N-acylphosphatidylethanolamine, a gut- derived circulating factor induced by fat ingestion, inhibits food intake Mol Ther 18 635-131
[48]  
Dervyn E(2011)Specialized adaptation of a lactic acid bacterium to the milk environment: the comparative genomics of Vaccine 29 4102-796
[49]  
Devine KM(2014) LMD-9 Microbiology 160 2341-2994
[50]  
Doherty G(2006)A new plasmid vector for DNA delivery using lactococci Biotechnol Bioeng 94 710-111